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I n t r o d u c t i o n
Cancer is the leading cause of death in Korea, with approximately
178,000 people developing cancer annually and 70,000 deaths reported
in 2008 [1]. The Korean government established the Comprehensive
10-Year Plan for Cancer Control in 1996 to reduce cancer burden at
the national level. National cancer control programs were formulated
and have been implemented since 1996. As part of these programs,
guidelines for cancer screening programs were developed and initiated
in 1999 [2].
Cancer screening of a population may be opportunistic, part of an
organized program, or a combination of the two. The primary dis-
tinction between opportunistic and organized screening is that the
target population is selected from centralized population registers in
organized programs [3]. Organized screening programs have nationally
implemented guidelines that define who should be invited to
participate in screenings, how frequently they should be screened, and
how abnormalities detected on screening should be followed up and
treated. In contrast, with no central register, opportunistic screening
depends on the decision of an individual to seek screening or on the re-
commendation of a health-care provider.
Purpose
The Korean National Cancer Screening Survey (KNCSS) is a continuous nationwide survey
implemented by the National Cancer Center in Korea since 2004. The purpose of the present
study was to report trends in cancer screening rates for the five major cancers (stomach,
liver, colorectal, breast, and cervix uteri) in Korean men and women. 
Materials and Methods
The study used KNCSS data collected between 2004 and 2010. The survey was conducted
on Korean men aged 40-74 years and Korean women aged 30-74 years with no history of
cancer diagnosis. The annual percentage change and corresponding 95% confidence
intervals were used to examine changes in annual screening rates.
Results
Screening rates with recommendation increased by 4.4% annually for stomach cancer, 1.5%
for liver cancer, 2.8% per year for colorectal cancer, 4.5% for breast cancer, and 1.2% for
cervix uteri cancer. The increasing trend in cancer screening rates, with the exception of
liver cancer, was significant. 
Conclusion
Cancer screening rates have increased consistently from 2004 to 2010 among Korean men
and women. Stomach and breast cancer screening rates in particular have increased
markedly. 
Key words
Early detection of cancer, Trends, Health care surveys 
In Korea, both organized and opportunistic cancer screening pro-
grams have been widely used. The organized programs include the Na-
tional Cancer Screening Program (NCSP) and the cancer screening
services carried out by the National Health Insurance Corporation
(NHIC) [4-6]. The NCSP for stomach, breast, and cervix uteri cancer
was established in 1999 to increase access to cancer screening services
for Medical Aid Program (MAP) recipients. Since 2002, the NCSP has
gradually extended its target population to National Health Insurance
(NHI) recipients. Liver cancer screening programs for a high-risk
group were added to the NCSP in 2003, and colorectal cancer
screening was implemented in 2004. Currently, the NCSP provides
MAP recipients and lower than 50% of NHI recipients with free-of-
charge screening services for the five most common cancers, which are
stomach, liver, colorectal, breast, and cervical cancers. The upper 50%
of NHI recipients not covered by the NCSP are enrolled in the or-
ganized cancer screening program run by the NHIC.
The aim of the present study was to report trends in overall screening
rates among Korean men and women in opportunistic and organized
cancer screening programs and to evaluate policies on cancer screening
programs implemented at the national level to reduce the cancer
burden. 
M a t e r i a l s  a n d  M e t h o d s
The present study used Korean National Cancer Screening Survey
(KNCSS) data from 2004 to 2010. The KNCSS is a continuous
nationwide survey that has been conducted by the National Cancer
Center since 2004. To obtain a nationally representative sample, the
KNCSS study population was selected based on Resident Registration
Population data using a stratified, multistage, and random sampling
procedure according to geographic area, age, and gender.
Investigators from a professional research agency conducted face-to-
face interviews in participant homes, except in 2004 when the data was
collected using computer-assisted telephone interviews. The subjects in
the present study were recruited by door-to-door contact, and at least
three attempts to contact a resident at each dwelling were made. The
response rates were 34.8-58.3% between 2005 and 2010. Informed
consent was obtained from all study participants. General characteri-
stics of the survey respondents for each year are shown in Appendix 1.
Eligibility was restricted to respondents with no history of a cancer
diagnosis. The respondents were asked about their screening
experience with the five common cancers, which were stomach, liver,
colorectal, breast, and cervix uteri. The current recommended
screening guidelines in Korea are the following: upper endoscopy or
upper gastrointestinal (UGI) series every 2 years for gastric cancer;
abdominal ultrasonography and serum α-fetoprotein every 6 months
for liver cancer; fecal occult blood test (FOBT) every year, double-
contrast barium enema every 5 years, or colonoscopy every 10 years
for colorectal cancer; mammography every 2 years for breast cancer;
and conventional cytology every 2 years for cervical cancer.
According to these guidelines, we limited our analyses to cancer-free
men aged 40 years and over and women age 30 years and over. The
gastric cancer screening survey participants were men and women
aged over 40 years, and the subjects in the colorectal cancer survey
were men and women over 50 years of age. Women over 40 were
included in the breast cancer screening survey, and women over 30
were included in the cervical cancer survey. Liver cancer screening
was restricted to high-risk groups such as people positive for the
hepatitis B virus surface antigen, the hepatitis C virus antibody, or
cirrhosis of the liver. Thus, the survey for liver cancer screening was
performed in high-risk men and women over 40 years of age.
Questions were developed to assess the uptake of each of the five
cancer screening programs. Previous cancer screening experience was
assessed by asking participants: (a) whether they had ever been
screened for a specific cancer by a screening modality, and (b) when
they underwent their most recent screening. Screening rates were
calculated from the proportion of men and women who responded
‘yes’ to question (a). ‘Lifetime screening’ was defined as ever having
had a screening test and was derived from question (a) by collapsing
across all types of screening tests. For ‘screening with recommen-
dation,’ participants in the targeted age group for the relevant cancer
who underwent screening were determined from the response to
question (b) taking the cancer screening guidelines into consideration.
Despite the 6-month interval for liver cancer screening, screening with
recommendation was defined as a screening test performed within 1
year. Changes in the annual screening rates were assessed by calcula-
ting the annual percentage change and the corresponding 95%
confidence intervals [7]. 
Furthermore, subgroup analyses by gender, age, and income level
were performed. Income level was determined by monthly household
income and classified into three groups by tertiles for each year. Liver
cancer was excluded from the subgroup analyses because of too few
subjects, and the data were not stable from year to year.
R e s u l t s
Screening with recommendation and lifetime screening rates in-
creased steadily from 2004. Between 2004 and 2010, screening with
recommendation rates increased annually by 4.4% for stomach cancer,
1.5% for liver cancer, 2.8% for colorectal cancer, 4.5% for breast can-
cer, and 1.2% for cervix uteri cancer (Table 1). We found a significant
increase in the screening with recommendation rate for all types of can-
cer except liver cancer (Table 1). Trends in the screening rate differed
according to the screening method. For example, stomach cancer
screening using upper endoscopy increased more rapidly than
screening using the UGI series (4.6% vs. 2.2% per year, respectively).
The increase in the trend for colorectal cancer screening using the
FOBT was steeper than that for overall colorectal cancer screening
(3.5% vs. 2.8% per year, respectively).
The trend in colorectal screening rates among men in the re-
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Fig. 1. Cancer screening rates by sex, 2004-2010.
Fig. 2. Cancer screening rates by age group, 2004-2010.
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commended screening population was slow in comparison to the
increase in the gastric cancer screening rates. The trend in stomach and
breast cancer screening rates among women in the recommended
screening population increased steeply, but despite the high screening
rate for cervix uteri cancer, the trend in the uptake of cervical cancer
screening plateaued in recent years (Fig. 1). According to age groups,
increasing trends in cancer screening rates for individuals in the
recommended screening population were observed across the board,
particularly in women aged 70 and over for breast cancer screening and
in women aged 60 and over for cervical cancer screening (Fig. 2).
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In 2004, the screening rates for stomach, colorectal, breast, and
cervix uteri cancer among the screening with recommendation
participants were lower in the low-income group than in the middle-
and high-income groups. However, the increment in the screening rate
was greater in the low-income group compared to the middle- and
high-income groups, and by 2010, the screening rates were similar for
all income levels (Fig. 3). An increase in the trend for cervix uteri can-
cer screening was observed only in low-income women. 
D i s c u s s i o n
Screening rates for stomach, liver, colorectal, breast, and cervix uteri
cancer have steadily increased since 2004. The screening rate for
cervical cancer exceeded 60% in 2009 and those for stomach and
breast cancer reached 61.1%, and 65.1%, respectively, in 2010. These
rates are close to the 70% screening rate target of the Second-term 10-
Year Plan for Cancer Control with recommendation in Korea [8].
In the United States [9,10], where screening is predominantly
opportunistic, the breast cancer screening rate using mammography
(women aged≥40 years) was 67% and the cervical cancer screening
rate using the Pap smear test (women aged≥18 years) was 78% in
2005. The trend in breast cancer screening rose until 2000, remained
stable until 2003, and fell slightly in 2005. The trend for cervical cancer
screening rose until 2000 and then declined slightly. 
In the United Kingdom, where nationwide organized screening
programs have been implemented, 73.7% of women aged 45-74 years
underwent mammography screening in 2008-2009, showing a slight
increase from the 2007-2008 rates [11]. The 5-yearly coverage of
cervical cancer screening using the Pap smear test was 78.9% in
women aged 25-64 in 2009-2010 [12]. The coverage of cervical cancer
continued to fall slightly from 80% in 2008-2009, particularly in
women aged 50-64. This finding reflects a downward trend in
screening uptake in this age group, and the first time coverage has
fallen below the target of 80% in the United Kingdom.
According to a Japanese study [13], the screening rate for stomach
cancer was 11.8% in 2007, showing a declining trend. The screening
rate for cervix uteri cancer had declined since 1991, but recently in-
creased to 18.8% in 2007. The screening rate for breast cancer in-
creased dramatically in 2005 and showed a steadily increasing trend up
to 14.2% in 2007. The screening rate for colon and rectal cancer in
Japan increased by 0.5% per year and was 18.8% in 2007.
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Fig. 3. Cancer screening rates by income level, 2004-2010.
The National Cancer Control Plan in Korea has led to several impro-
vements in cancer screening in addition to increasing participation in
screening. First, socioeconomic disparities in the use of cancer
screening programs have decreased from year to year. Second, an
increasing number of Korean men and women in the targeted aged
groups for the relevant cancers have undergone screening tests accor-
ding to the recommendations. Although the influence of opportunistic
screening cannot be ruled out, the introduction of the NCSP has played
an important role in improving the use of screening in Korea.
The KNCSS conducted a nationwide survey to investigate
participation rates in cancer screening for five kinds of cancers in
Korea and reported the current status. However, this survey has several
limitations. First, our results relied on self-reported data. Some tests
may have been performed following a physician’s order for other pur-
poses because screening tools such as endoscopies are used not only
for cancer but also for the diagnosis and follow-up of other diseases.
Although survey data from self-reported interviews may have intro-
duced a misclassification bias, many studies have shown the reliability
of self-reported histories of cancer screening, which have been shown
to agree well with medical records [14,15]. Second, although our
response rates (34.8-58.3%) were acceptable in Korea [16,17], it may
have nonetheless produced a non-response bias. In general, the
preventative health behaviour patterns of survey participants may differ
from those who refuse to participate [18]. For example, those with
more interest in gastric cancer screening may have been more likely to
participate in the survey.
C o n c l u s i o n
The KNCSS is the ongoing systematic collection, analysis, and
interpretation of data essential to the planning, implementation, and
evaluation of nationwide cancer screening policies in Korea. These
efforts will provide decision-makers with guidance for developing and
implementing the best strategies to use in screening programs for
cancer prevention and control in Korea.
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